Home
COVID-19
COVID-19
COVID-19 Vaccine Access
COVID-19 Vaccine Manufacturing
COVID-19 Vaccine R&D Funding
COVID-19 Data Resources
Research Syntheses
Overview of Research Syntheses
Advanced Market Commitment
Affordability
Biosecurity R&D
Competition Law
Compulsory Licensing
Data Exclusivity*
Donations
Drug Development Histories*
Health Technology Assessment
Institutions
Mark-ups, Taxes, Supply-chain Costs
Parallel Import
Pooled Procurement
Price Controls/Regulation
Patentability criteria
Parallel Import
Patent Pools
Priority Review Vouchers
Product Development Partnerships
Public Funding of R&D
R&D Costs
Shortages
R&D Time and Success Rate
Shortages
Small and Medium Enterprises
Tiered Pricing
TRIPS-Plus / Trade Agreements*
Voluntary Licencing
Data Sources
Overview of Data Sources
National Price Data
Regional and Global Price Data
Pharmaceutical Company Policies
Other Price Data
Contractual Provisions of Agreements
Patent Information
Trade Agreements
TRIPS Flexibilities
Other IP Data
Alternative Models of R&D
Clinical Trials Registries
Costs of R&D
Health Product Profiles
Priority Review Vouchers
R&D Funding
Research Gaps
Webinars
About Us
Search
More
Use tab to navigate through the menu items.
DATA SOURCES
A resource gathering relevant open data sources related to medicines prices, intellectual property and innovation.
NEW! Dedicated page for COVID-19 data sources
Prices
National Price Data
Regional and Global Price Data
Pharmaceutical Company Policies
Other Price Data
Intellectual Property
Patent Information
Pharmaceutical Company Policies
Contractual Provisions
Trade Agreements
TRIPS Flexibilities
Other IP Data
Innovation
Alternative R&D Models
Clinical Trial Registries
Cost of R&D
Health Product Profiles
Priority Review Vouchers
R&D Funding
Pharmaceutical Company Policies
This work is licensed under a
Creative Commons Attribution 4.0 International License
.
